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Abstract
Background—Patterns of non-invasive stress test (ST) and invasive coronary angiography (CA)
utilization after percutaneous coronary intervention (PCI) are not well described in older
populations.
Methods and Results—We linked National Cardiovascular Data Registry® CathPCI
Registry® data with longitudinal Medicare claims data for 250,350 patients undergoing PCI from
2005 to 2007 and described subsequent testing and outcomes. Between 60 days post-PCI and end
of follow-up (median 24 months), 49% (n=122,894) received stress testing first, 10% (n=25,512)
underwent invasive CA first, and 41% (n=101,944) had no testing (NT). A number of clinical risk
factors at time of index PCI were associated with decreased likelihood of downstream testing (ST
or CA, p<0.05 for all), including older age (HR 0.784 per 10 year increase), male sex (HR 0.946),
heart failure (HR 0.925), diabetes (HR 0.954), smoking (HR 0.804), and renal failure (HR 0.880).
Fifteen percent of patients with ST first proceeded to subsequent CA within 90 days of testing
(n=18,472/101,884); of these, 48% (n=8831) underwent revascularization within 90 days,
compared to 53% (n=13,316) of CA first patients (p<0.0001).
Conclusions—In this descriptive analysis, stress testing and invasive CA were common in older
patients after PCI. Paradoxically, patients with higher-risk features at baseline were less likely to
undergo post-PCI testing. The revascularization yield was low on patients referred for ST after
PCI, with only 9% undergoing revascularization within 90 days.
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Diagnostic testing is commonplace following the 1.4 million percutaneous coronary
intervention (PCI) procedures performed annually in the United States1,2 and is addressed in
the American College of Cardiology/American Heart Association (ACC/AHA) guidelines3-5
and the American College of Cardiology Foundation (ACCF) Appropriate Use Criteria
(AUC).6,7 There has been accumulating scrutiny regarding the overall increased use of
cardiac diagnostic testing in recent decades8 with studies suggesting high testing rates in
patients after PCI,9 as well as significant geographic variability10 and financial influences on
testing rates.11 Yet despite these concerns, limited data exist on current patterns of post-PCI
cardiac testing and the subsequent need for repeat revascularization or other associated
outcomes.
A better understanding of the predictors and downstream impact of imaging after PCI
requires both rich clinical characteristics and longitudinal outcomes data. Therefore, we
examined patterns of stress testing (ST) and invasive coronary angiography (CA) after PCI
in a large, contemporary cohort using a unique dataset, which combined the Centers for




All patients >65 years receiving PCI with stenting, admitted and discharged between
January 1, 2004 and December 31, 2008, and enrolled in the CathPCI Registry (with
subsequent date restrictions, described below, for the final study population) were included.
The CathPCI Registry is a large, national, clinical registry of patients undergoing cardiac
catheterization or PCI.12,13 The first PCI with a stent procedure for each admission was
considered the index event and was the initial unit of analysis; there were 672,617 eligible
index events.
CathPCI Registry index events were matched to Medicare inpatient claims data using
indirect identifiers to link unique admissions.14 Index CathPCI Registry events lacking
Medicare inpatient claims (including procedures performed in the outpatient setting or at
Veterans Affairs Administration hospitals, and procedures paid through Medicare managed
care plans, employer-sponsored plans, or private insurance plans) could not be matched.
Even so, using this methodology we successfully linked 443,922 index events to an
admission in the Medicare data, or 67% of all eligible index events. After matching, only the
first PCI for each patient was considered. Due to changes in the CathPCI Registry data
collection form, and to allow for >1 year of potential follow-up for included patients, the
final population for this study was limited to patients with index PCI events between
January 1, 2004 and December 31, 2008. Patients who did not have fee-for-service Medicare
coverage for the entire follow-up period were censored at the end of coverage. Additional
exclusion criteria were applied (Figure 1).
A 60-day blackout period after PCI was defined for each patient, since diagnostic tests
during this period may be performed for the purposes of cardiac rehabilitation, staging of
procedures, or functional capacity assessments, and were not considered as post-
revascularization stress tests or outcome events.
Data Definitions
Inpatient and outpatient stress test procedures, CA, coronary revascularization (PCI and
coronary artery bypass graft surgery), and acute myocardial infarction (MI) after PCI were
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identified by Healthcare Common Procedure Coding System (HCPCS) Current Procedural
Terminology (CPT) and International Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM) codes, as described in Appendix 1. Date of death was obtained
from the CMS beneficiary claim files.
Statistical Analysis
Patients were stratified by type of first follow-up test (no testing [NT] compared to any
testing [AT], and ST first compared to CA first among those with testing) between the 60-
day post-PCI blackout period and end of follow-up. Given our intended focus on diagnostic
testing patterns outside of the acute setting, patients were classified only according to testing
status prior to any MI admission or death; patients with first post-PCI testing during or after
an MI admission were therefore counted in the NT group. Patients with ST and CA on the
same day were included in the ST first group.
All statistical tests were two-sided with a significance level of 0.05. P-values were based on
either Pearson chi-square tests for categorical variables or Kruskal-Wallis tests for
continuous or ordinal variables. Due to variable follow-up time between groups, p-values
were not reported for between-group comparisons, as in Table 1. We set a threshold of
greater than 2% absolute difference between groups for reporting.
Time-to-first test (ST or CA) occurring between 60 days and one year after the index PCI
were computed and plotted using cumulative incidence functions that accounted for
administrative censoring and included MI hospitalization and death as competing risks.15
One-year cumulative incidence of ST first or CA first was compared to NT using an
unadjusted Poisson regression stratified by calendar quarter of index PCI, to determine if
testing patterns changed over the study period.
To evaluate the association of baseline variables with type of first downstream test, if any,
we developed cause-specific Cox proportional hazards models16,17 to estimate hazard ratios
of AT vs. NT, and ST first vs. CA first among those with testing, for a panel of baseline
variables from available NCDR variables selected a priori, listed in Appendix 2. In each
model, patients were censored at date of testing, MI admission, death, end of follow-up, or
at 12 months after PCI.
Patterns of layered testing and procedures after PCI were evaluated by identifying the first
test (ST first, CA first, or NT) at least 60 days after the index PCI procedure and prior to MI,
and calculating rates of subsequent procedures (repeat ST, CA, and revascularization)
between 0 and 90 days from that first post-PCI test, but prior to MI hospitalization or death.
“Catheterization yield” rates were computed by dividing the revascularization rate by the
CA rate (either CA first or CA within 90 days of first test).
In an exploratory observational analysis, we examined clinical outcomes following different
first test types using the composite endpoint of death or MI admission. We fit an adjusted
Cox model with a time-varying covariate indicating first testing status (no test/pre-testing,
STF, or CAF) to account for differences in timing of testing and death or MI.18 For this
analysis only, following the 60-day blackout period after PCI all patients started in the NT/
pre-testing group and remained in that group until undergoing a first test, at which time they
moved to the ST first or CA first group, as appropriate. If an MI occurred during the same
hospitalization as a CA first, we assumed that the CA was a diagnostic or therapeutic
intervention for that MI, and the MI was attributed as an event to the “NT/pre-testing”
group. We censored at the end of follow-up, first MI, or death, adjusting for the same
baseline variables as in the Cox model for testing status. For ease of discussion, the “NT/
pre-testing” group is referred to as the NT group in the Results and Discussion sections of
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this paper. All statistical analyses were performed using SAS version 9.2 or higher (SAS
Institute Inc., Cary, NC) and Stata Statistical Software: Release 11 (StataCorp, College
Station, TX). The Duke University Medical Center Institutional Review Board granted a
waiver of the informed consent and authorization for this study.
Results
The study population included 250,350 Medicare patients with qualifying PCI entered in the
CathPCI Registry and matched to Medicare claims data between January 1, 2005 and
December 31, 2007, with follow-up data through December 31, 2008 (Figures 1a and 1b).
Median age at time of index PCI was 74 years, 43% were female, and median follow-up
time was 728 days (inter-quartile range [IQR]: 491-1028 days). Among these PCI patients,
122,894 (48.9%) underwent ST first, 25,512 (10.2%) received CA first, and 101,944
(40.7%) had NT between 60 days after PCI and end of follow-up, and before any MI
admission or death.
Patient and Hospital Characteristics by Follow-up Testing Status
“Any Testing” vs. “No Testing”—Patients who underwent either ST or CA at any time
during follow-up differed at the time of index PCI from those who did not have subsequent
testing (NT patients) (Table 1). No testing patients were older with a greater proportion aged
at least 75 years, had higher rates of major comorbidities, including prior CHF diagnosis,
diabetes, renal failure, cerebrovascular disease, chronic lung disease and current smoking.
No testing patients were less likely to have had previous PCI or to have presented with
angina, but more likely to have had acute MI and/or congestive heart failure (CHF) at the
time of PCI. Any testing patients underwent PCI at centers with higher median annual PCI
volume, were more likely to have received drug-eluting stents, and were less likely to have
been treated at academic centers.
Rates of pre-PCI testing were clinically similar for patients with any testing post-PCI
compared to no testing (78% vs. 77%, respectively), with very similar distribution of
positive, negative, and equivocal results. Stress testing during the blackout period did not
appear to preclude the use of testing after the blackout period, as AT patients were more
likely to have had ST during the blackout period than NT patients, 14% vs. 9%. In contrast,
there was no difference in ST use in the blackout period between post-blackout ST and CA
patients, 14% in each group.
“Stress Test First” vs. “Coronary Angiography First”—Among patients with post-
PCI testing at any time during follow-up (prior to MI hospitalization), ST first patients had
lower baseline rates of most risk factors and comorbidities than CA first patients. Stress test
first patients were less likely to have comorbid conditions, and were less likely to have had
unstable angina or CHF at time of index PCI, but received drug-eluting stents more
frequently. The time from PCI to testing was shorter for CA first patients, and they were
treated at centers with higher median PCI volumes.
Patterns of Testing and Procedures within One Year after PCI
The cumulative incidences of CA first, ST first, and death or MI first between 60 days and
one year after index PCI were examined to compare overall temporal trends (Figure 2) and
30-day incremental incidences (i.e., the incidence of testing or death/MI in patients not
previously having an event; Figure 3). Accounting for censoring and competing risks, the
cumulative incidence from 60-365 days after index PCI of CA first was 7.6%, of ST first
was 32.8%, and of death or MI first was 6.0%. The remaining patients (55.6%) were alive
without testing one year after PCI. For both ST first and CA first, the incremental 30-day
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incidence of testing declined gradually over the first year after PCI. However, there are
notable upticks in ST incidence in the 180-209 day range and the 330-359 day range,
suggesting an increase in testing at 6-month and 1-year, possibly related to the time of
routine follow-up visits. No similar pattern is apparent for 30-day incremental incidence of
CA or death/MI.
The cumulative incidence of AT (ST or CA) within one year of index PCI declined from
41.9% in Q1 2005 to 38.0% in Q4 2007 (date of PCI). This decline was driven by a fall in
ST incidence from 34.3% to 30.5% (p<0.0001) with decreases primarily in nuclear stress
testing, 28.9% to 25.5%, p<0.0001. The incidence of CA was stable such that the likelihood
of ST first relative to CA first decreased over time (Table 2).
Predictors of Testing after PCI
Cause-specific Cox models (with censoring at death, MI, end of follow-up, or 12 months)
were used to calculate hazard ratios for AT (ST or CA) compared to NT within one year of
index PCI (after the 60-day “blackout” period and prior to MI) for 30 baseline variables
(Figure 4). Predictors of AT included female sex, non-white race, prior PCI, and receipt of
bare metal stent(s). Most comorbidities and cardiac risk factors were associated with lower
hazard ratios for AT, including: increasing age, prior CHF or MI, presentation with CHF at
time of index PCI, diabetes, smoking, renal failure (dialysis or glomerular filtration rate less
than 30 ml/min), cerebrovascular disease, and chronic lung disease.
Among patients with AT between 60 days and 12 months after PCI, a lower hazard of ST
first and a higher likelihood of CA first was associated with prior CHF, prior PCI, prior
CABG, diabetes, and chronic lung disease, but not sex or race. Acute coronary syndrome at
time of index PCI and receipt of bare metal stents were both associated with a higher
likelihood of ST first. The likelihood of ST first compared to CA first decreased over time.
Subsequent Testing and Clinical Outcomes
We examined downstream testing patterns within a 90-day episode of care period after the
first post-PCI test, censoring for MI (Table 3). Among ST first patients (n=122,894), 2%
(n=3016) had a second ST next, 83% (n=101,884) had no further cardiac testing, and 15%
(n=18,472) proceeded to CA, of whom 48% (n=8831; 7% of the ST first group) had
coronary revascularization. Repeat stress testing was not associated with an increased
likelihood of revascularization.
For CA first patients (n=25,512), 4% (n=953) had ST next within 90 days, 44% (n=11,210)
had no further testing, and 53% (n=13,316) proceeded to revascularization. Of patients
referred to ST next after CA first who then returned to CA, 78% (n=96; 10% of the CA first
patients with ST next) received revascularization.
In an unadjusted model treating testing status as a time-varying covariate, the hazard of
either death or MI was higher after CA first (hazard ratio [HR] 1.20, 95% confidence
interval [CI] 1.16-1.25, p<0.0001) and lower after ST first (HR 0.65, 95% CI 0.63-0.66,
p<0.0001), relative to NT. After adjusting for baseline covariates (but without information
about clinical presentation at time of post-PCI testing unavailable in this database), the
results were similar: CA first vs. NT was associated with a 27% increase in likelihood of
death or MI (HR 1.27, 95% CI, 1.23-1.32, p<0.0001) and ST first vs. NT was associated
with a 19% reduced likelihood of death or MI (HR 0.81, 95% CI 0.79-0.83, p<0.0001).
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In this detailed analysis of contemporary patterns of cardiac testing among over 250,000
Medicare patients, we found that ST and CA were common within the first two years after
PCI. Patterns of use suggest that patients with higher risk were less likely to undergo any
post-PCI testing, and revascularization yield was low after post-PCI testing.
Our findings extend Shah et al.’s observation that 61% of privately insured patients <65
years old undergo ST within 2 years of PCI.9 In the current study, 59% of elderly patients
underwent cardiac testing between 60 days after PCI and end of follow-up, with ST first in
49% of patients and CA first in 10% of patients. In both studies, these rates greatly exceed
the 15% one-year rates of angina symptoms in previous registry reports.19 As in Shah et
al.’s younger, commercially-insured cohort, we noted increased incremental ST rates at 6-
months and 12-months post-PCI that may reflect a pattern of routine surveillance testing
contrary to guidelines and AUC (though it is also possible that patients do not report
concerning symptoms until scheduled visits, at which time symptom-driven testing may be
ordered). The consistencies across these two studies, despite substantial differences in age
and reimbursement mechanisms, demonstrate that testing is common after PCI across a
broad range of patients, and these findings likely represents general patterns of care
nationwide.
In aggregate, these observations suggest that there may be opportunities to improve the
selection of patients for ST and CA after PCI. Over the time period studied we did see a
modest but significant decline in testing rates after PCI driven by declines in ST rates,
especially nuclear stress tests. This finding is consistent with reports of slowing growth in
the setting of decreasing reimbursement rates following passage of the Deficit Reduction
Act of 2005, the introduction of the ACC AUC standards,6,7 and a growing focus on
ensuring appropriate indications for testing over the years of the study period.20
Unlike other studies we were able to examine the implications of baseline clinical
characteristics on subsequent care, finding that increasing age, male sex, and most
comorbidities were associated with a lower likelihood of AT after PCI. Previous research
has shown that ACS patients at highest baseline risk, and potentially with the most to gain
from treatment, are often less likely to receive evidence-based therapies than healthier
counterparts.21-23 The current study suggests there may be a similar “paradoxical care”
dynamic in testing after PCI, with lower testing rates among those most at risk; however,
whether more testing would lead to better or worse outcomes cannot be determined in this
observational study.
Among patients who did receive testing after PCI, comorbidities and risk factors were
generally more common among CA first patients compared to ST first patients. This finding
presumably reflects the guideline-supported tendency to refer higher risk patients directly to
CA. Yet surprisingly, ACS presentation at the time of index PCI increased the likelihood of
ST first rather than CA first—the reasons for this association are unclear.
Our study also highlights opportunities for identifying optimal testing strategies after PCI.
We found that patients referred to ST first had only a 15% rate of subsequent cardiac
catheterization, but the “catheterization yield” (i.e., rate of revascularization following
catheterization) was clinically similar, though statistically different, between ST first and
CA first patients (48% vs. 53%, p<0.0001). Though the ideal yield is impossible to
determine, these “coin flip” rates underscore the challenges inherent in the contemporary
evaluation of suspected ischemia, even in patients with known CAD and a history of
revascularization. These findings highlight the need for improved methods to assess pre-test
risk before and in addition to non-invasive or invasive testing.
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Although we did not have clinical data at time of repeat testing, an exploratory analysis to
evaluate clinical outcomes after post-PCI testing showed diametric differences in the hazard
of death or acute MI with different post-PCI testing patterns. Invasive coronary angiography
first patients had a 20% higher unadjusted hazard (27% adjusted) of the combined endpoint
relative to NT, despite attribution of MIs that occurred during the same hospitalization as the
initial CA to the NT group. In contrast, following ST first, there was a 35% lower
unadjusted hazard of death or MI, relative to NT. After adjustment, the hazard decrement
was lower, but still significant at 19%.
In this observational study, we cannot address causality, nor can we determine the extent to
which observed differences in associated outcomes reflect unmeasured baseline differences,
variations in clinical presentation or status at time of testing (confounding by indication), or
differential effectiveness of testing strategies. Therefore, we do not intend to imply that test
selection after PCI is a primary driver of clinical outcomes. Even so, the antipodal
associations of CA first and ST first with clinical outcomes are notable and deserving of
further research attention, potentially through randomized studies or the use of “natural
experiments” in observational datasets.
Strengths and Limitations
Using a unique data set linking detailed baseline clinical information from the CathPCI
Registry with longitudinal inpatient and outpatient Medicare fee-for-service claims data, we
have analyzed testing patterns after PCI in a large, nationwide cohort of patients receiving
care in “real world” clinical practice. We are not aware of any prior similar study of this
magnitude. Nevertheless, data are limited to fee-for-service Medicare patients who
underwent index PCI with inpatient Medicare billing at CathPCI Registry sites, and may not
be generalizable to other populations. Only 67% of index NCDR PCI events were linked to
longitudinal Medicare billing data; however, in a cohort of elderly PCI patients from
2004-2006 developed using the same methodology, linked and unlinked patients shared
similar demographic and clinical features.24 Data on symptoms, clinical presentation, and
findings at the time of retesting were unavailable and surely differed between groups. The
indications for and goals of testing were not available. Our dataset allowed only evaluation
of medium-term testing patterns and outcomes, and longer-term results may diverge.
Conclusions
In contemporary practice, ST and CA are utilized frequently after PCI, with patterns of use
suggesting that patients with higher risk are less likely to undergo post-PCI testing. Further
research is warranted to identify ideal testing indications and strategies after PCI, and to
determine the impact of testing strategies on clinical outcomes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1a. Linked dataset population description
This figure displays the linked dataset population (CathPCI and CMS), exclusions included.
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Figure 1b. Study population description
This figure displays initial patient cohort, through the final study population, exclusions
included.
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Figure 2. Cumulative incidence of stress test first, coronary angiography first, or death/
myocardial infarction within 1 year and at least 60 days after index PCI
This figure displays the cumulative incidence of stress testing, coronary angiography or
death/myocardial infarction in patients without a previous event, treating each type of event
as a competing risk for the other types.
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Figure 3. 30-day incremental incidence of stress test first, coronary angiography first, or death/
myocardial infarction between 60 days and 1 year after index PCI
This figure displays the incremental incidence of stress testing, coronary angiography, or
death/myocardial infarction per 30 day period in patients without a previous event, treating
each type of event as a competing risk for the other types.
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Figure 4. Hazard ratios associated with a risk of any test
Hazard ratios associated with a risk of stress test or coronary angiography compared to no
test and risk of stress test first compared to coronary angiography first between 60 days and
12 months after PCI by baseline characteristics determined at time of index percutaneous
coronary intervention.
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Table 3
Rates of Stress Testing, Coronary Angiography, and Revascularization after First Test Post-PCI (if any, within
90 Days of first Test after Index PCI and prior to Death or Myocardial Infarction Admission)
First test after index PCI
STF (n=122,894) CAF (n=25,512)
No subsequent test 83% 44%
Stress test next 2% 4%
Catheterization within 90 days 15% N/A
Revascularization within 90 days 7% 53%
Catheterization yield
* 48% 53%
All p-values <0.0001 for all comparisons
All abbreviations can be found in Table 1.
*
Catheterization yield = revascularizations within 90 days divided by catheterizations within 90 days
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